Tag Archives: drugs

Gilead Is Looking Good

Is it time to buy Gilead Sciences?

The upcoming transits to the First-Trade horoscope, as well as other Gilead dynamics, identify this stock as a good trading candidate now.

Gilead transits to First-Trade
Transits to the Gilead Sciences First-Trade Horoscope

Gilead Sciences, Inc. (NASDAQ – GILD) is a research-based biopharmaceutical company.

Headquartered in Foster City, California, Gilead discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and elsewhere around the world.

The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.

Gilead also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; and Zydelig, a kinase inhibitor.

It makes Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections.

In addition, the company offers its products under a variety of other brand names. They include Cayston, Emtriva, Hepsera, Sovaldi, and Tybost.

Gildead also develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology.

The company markets its products through its commercial teams. It also works in conjunction with third-party distributors and corporate partners.

Positive Transits for Gilead

Transiting Saturn conjoining the Gilead First-Trade Sun could provide a more favorable entry point for a long position here. While Saturn is associated with contraction, it can provide a basis for further price advancement in a case like this.

And that’s not all.

The potential for higher prices ahead and an increase in speculative energy is indicated by transiting Neptune conjoining the First-Trade Ascendant.

On top of that, transiting Venus is forming a quincunx to First-Trade Neptune. That’s very nice for a drug company!

In other words, this looks like a solid setup for a good buying opportunity for this stock.

Yesterday we added Gilead to our watch list for our members at FinancialCyclesWeekly.com.

Our astro-trading trend chart shows why. Note the recent price gap upward.

Geocentric planetary price lines for Mars and Jupiter in the eighth harmonic help reveal the trading structure for Gilead.

Arch Crawford Talks War

Arch Crawford was the first thing Larry Pesavento mentioned when I joined him on his show yesterday.

Arch Crawford
Arch Crawford

“Tim,” he said, “we had one of your biggest fans on yesterday – Arch Crawford!”

I told Larry that I indeed consider Arch Crawford a dear friend.

He’s also one of the best-know financial astrologers.

But, Larry said, Arch told his audience that current astrological alignments point to to the possibility of war before the end of the month.

His latest forecast has been stirring up some very concerns.

That’s why Larry Pesavento had brought him on his Trade What You See program on TFNN the previous day. Arch had had an opportunity then to fill in some the details about what he’s seeing for the weeks ahead.

What Arch Crawford Had To Say

When Arch had been on Larry’s show on Wednesday, he warned of “hostility, terrorism and outright war” just ahead.

“This is a world condition,” he explained, “and as such it’s hard to determine who will and who will not be affected.

“It does touch our president’s horoscope chart, which increases the likelihood of US involvement.

“Neptune is highlighted, and there may be religious elements to certain areas of this turbulence, and perhaps drug connections as well to others.”

“These effects will likely take hold in the latter half of this month.

“This is not a joke!”

Do I Agree With This Forecast?

Quite naturally, Larry wanted to know if I agreed.

Does my own assessment match the view of Arch Crawford?

What’s really going on?

It was a great springboard for a very engaging conversation.

We not only talked about Arch and his forecasts.

We also discussed Y2K, bitcoin, and the current Mars alignments.

And we talked about current conditions in the stock market.

Here’s the entire interview segment: